New therapeutic strategy could target toxic protein in most patients with Huntington's disease
Thursday, April 9, 2009 - 12:35
in Health & Medicine
Howard Hughes Medical Institute researchers have designed tiny RNA molecules that shut off the gene that causes Huntington's disease without damaging that gene's healthy counterpart, which maintains the health and vitality of neurons.